Every breath you take is part of a profoundly ancient narrative, a biological symphony that has resonated through hundreds of…
Read More
Teva Pharmaceuticals Acquires Emalex Biosciences for $700 Million to Bolster Neurology Pipeline and Drive Growth Strategy
Teva Pharmaceuticals is set to significantly expand its presence in the neuroscience market with the acquisition of Emalex Biosciences, a…
Read More
Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both Companies
Canadian pharmaceutical giant Apotex has announced a significant strategic acquisition, agreeing to purchase Cumberland Pharmaceuticals’ entire portfolio of branded commercial…
Read More
Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
The Ancient Story of Every Breath You Take: 289-Million-Year-Old Fossil Reveals Earliest Rib-Based Breathing System in Amniotes
The seemingly mundane act of taking a breath, a process so fundamental to life that it often goes unnoticed, is…
Read More
Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline
Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…
Read More
This crocodile ran like a greyhound across prehistoric Britain 200 million years ago
The ancient landscape of what is now Gloucester, UK, once teemed with a remarkable array of prehistoric life, and a…
Read More
Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development
Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…
Read More
Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases
Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…
Read More
The Over 300-Million-Year-Old Pohlsepia May Be a Nautilus Called Paleocadmus
Paleontologists have unveiled a groundbreaking reclassification of a fossil previously identified as Pohlsepia, a purported ancient octopus. New research suggests…
Read More
